TLDR: Assort Health, a San Francisco-based company, has successfully raised $76 million in a Series B funding round. This capital infusion, secured on September 30, 2025, will be utilized to expand its agentic AI healthcare platform, which employs specialty-specific generative voice AI to manage patient calls, aiming to reduce operational costs and improve patient access to care.
San Francisco, CA – October 1, 2025 – Assort Health, a pioneering force in healthcare technology, announced today the successful closure of a $76 million Series B funding round on September 30, 2025. This significant investment is earmarked to accelerate the scaling of its innovative agentic AI healthcare platform, which leverages specialty-specific generative voice AI to transform patient communication.
The company’s core offering is a sophisticated generative voice AI system designed to answer patient calls, effectively eliminating long wait times and streamlining administrative tasks within healthcare organizations. This technology has already demonstrated substantial impact, having served over 9 million patient interactions.
Assort Health’s platform promises considerable operational efficiencies for healthcare providers, reporting a 63% reduction in operational costs and a 3% increase in net new patients. The system is also noted for its rapid deployment, with a typical go-live period of just five weeks.
Founded by Jon Wang and Jeff Liu, Assort Health aims to address critical challenges in traditional healthcare call centers, such as inefficient scheduling and high staff turnover, which often lead to patient frustration and barriers to care. The AI-powered voice agent integrates seamlessly with electronic health record systems, updating patient data, insurance information, and scheduling appointments in real-time.
Earlier funding rounds include a $26 million institutional financing round announced on April 16, 2025, co-led by First Round Capital and Chemistry, with continued support from Quiet Capital. This previous funding brought Assort’s total capital raised to $26 million at that time. The company’s technology has been adopted by numerous healthcare organizations, including Chesapeake Healthcare, OrthoIndy, Peninsula Orthopaedic Associates, and Cleaver Medical Dermatology.
Assort Health’s commitment to improving patient access and operational efficiency through AI was further highlighted by its announcement of the inaugural Assort Ascend Customer Summit, scheduled for September 19-21, 2025, in Napa Valley. This event is set to gather healthcare leaders to explore AI-driven solutions for patient engagement and provider operations.
Also Read:
- Confido Health Secures $10 Million Series A to Advance AI Voice Agents in Healthcare
- AI-Powered Recruiter Alex Secures $17 Million to Revolutionize Early-Stage Job Interviews
The latest $76 million Series B funding underscores investor confidence in Assort Health’s vision and its ability to deliver tangible benefits to the healthcare sector through advanced AI solutions.
